Plain-English translation of NCT07620535 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study is following people who have received a positive Shield screening result for colorectal cancer to understand how they make decisions about follow-up care. Researchers want to learn what factors help or prevent people from completing the recommended next step โ a diagnostic colonoscopy. The study simply observes your natural decision-making process and tracks whether you complete your follow-up testing, without trying to influence your choices.
Many people get screening results that need follow-up, but not everyone completes the recommended next steps. By understanding what affects these decisions, researchers hope to identify ways to help more people get the care they need and catch colorectal cancer early.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would participate in a decision counseling session to discuss your screening result and follow-up options. The researchers will then track your decisions and medical records to see whether you complete your recommended colonoscopy over time. This is an observational study, meaning the researchers are simply following your choices โ they won't try to change what you decide to do.
AI-generated summary from trial data ยท Nov 17, 2026 ยท Not medical advice
United States
Collaborators
Thomas Jefferson University
Enrollment target
~350 participants
Started
August 2026
Primary completion
December 2027
Age range
45 Years โ 75 Years
Last updated on clinicaltrials.gov in November 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Director of Clinical Trial Operations
Guardant Health, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.